Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | ferritin | 0.001 | 0.0868 | 0.0251 |
Schistosoma mansoni | ferritin | 0.001 | 0.0868 | 0.0767 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0868 | 0.0767 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.4088 | 0.9117 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.4678 | 0.4619 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.4088 | 0.9122 |
Schistosoma mansoni | ferritin | 0.001 | 0.0868 | 0.0767 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0939 | 0.0327 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.9966 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.4678 | 0.4334 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.4088 | 0.9122 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0017 | 0.1908 | 0.2845 |
Trichomonas vaginalis | ferritin, putative | 0.001 | 0.0868 | 1 |
Schistosoma mansoni | lamin | 0.0033 | 0.4088 | 0.4023 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Echinococcus multilocularis | lamin | 0.0033 | 0.4088 | 0.3701 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0016 | 0.1658 | 0.1097 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.9966 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.9966 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.4393 | 0.4331 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0634 | 0.0531 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Onchocerca volvulus | 0.0035 | 0.4393 | 1 | |
Echinococcus multilocularis | expressed protein | 0.001 | 0.0868 | 0.0251 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.9966 | 0.5 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0.0868 | 0.5 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0868 | 0.0767 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0.0868 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0525 | 0.6047 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.4002 | 0.8868 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.4678 | 0.4334 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.1658 | 0.2082 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.4393 | 1 |
Schistosoma mansoni | lamin | 0.0033 | 0.4088 | 0.4023 |
Echinococcus multilocularis | musashi | 0.0033 | 0.4088 | 0.3701 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.1908 | 0.2804 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.4678 | 0.4619 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0939 | 0.0327 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0868 | 0.0767 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.4088 | 0.9117 |
Echinococcus granulosus | expressed protein | 0.001 | 0.0868 | 0.0251 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.4088 | 0.9117 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.4088 | 0.3701 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.9966 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1572 | 0.1833 |
Schistosoma mansoni | ferritin | 0.001 | 0.0868 | 0.0767 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.4088 | 0.3701 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.4088 | 0.4023 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.4088 | 0.3701 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.9966 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0525 | 0.6047 |
Schistosoma mansoni | ferritin | 0.001 | 0.0868 | 0.0767 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.9966 | 0.9965 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.9966 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.9966 | 0.9965 |
Echinococcus granulosus | lamin | 0.0033 | 0.4088 | 0.3701 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0868 | 0.0767 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0.0868 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1572 | 0.1833 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0525 | 0.6047 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.9966 | 1 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.4393 | 1 |
Echinococcus multilocularis | ferritin | 0.001 | 0.0868 | 0.0251 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0016 | 0.1658 | 0.1097 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (binding) | = 3.5481 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.